Nautilus Biotechnology Cash Flow Statement (2020-2026) | NAUT

Cash Flow Statement Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Operating Activities
Net Income (Quarter)
Depreciation and Depletion (Quarter)
0.30M0.30M0.20M0.30M0.30M0.30M0.33M0.40M0.40M0.50M0.55M0.52M0.50M0.50M0.50M0.47M0.40M0.40M0.40M0.30M
Share-based Compensation (Quarter)
1.82M2.25M24.49M2.11M-2.11M7.55M2.83M2.86M4.76M1.44M-1.44M3.11M3.28M3.18M3.12M2.17M1.71M1.50M1.47M1.36M
Cash from Operations (Quarter)
-8.29M-14.18M-10.52M-12.34M-13.53M-9.56M-10.38M-12.52M-13.55M-11.74M-13.90M-16.27M-15.46M-13.11M-14.31M-13.94M-13.35M-11.03M-12.38M-13.10M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles (Quarter)
-0.10M0.02M0.01M-0.03M0.17M0.19M0.55M0.67M0.74M0.63M0.62M0.75M0.70M0.72M0.63M0.54M0.44M0.31M0.13M0.07M
Amortization of Deferred Charges (Quarter)
0.35M0.46M0.61M0.53M0.55M0.55M0.57M0.79M1.02M1.01M1.03M1.07M1.08M1.10M1.12M1.16M1.18M1.19M4.20M1.14M
Depreciation & Amortization (CF) (Quarter)
0.30M0.30M0.20M0.30M0.30M0.30M0.33M0.40M0.40M0.50M0.55M0.52M0.50M0.50M0.50M0.47M0.40M0.40M0.40M0.30M
Change in Working Capital
Change in Account Payables (Quarter)
0.00M0.16M0.37M-0.39M-0.25M-0.21M0.29M0.05M-0.25M0.22M0.37M0.09M-0.40M0.27M-0.54M-0.13M0.08M-0.02M0.00M0.20M
Change in Accured Expenses (Quarter)
0.42M1.12M0.72M0.31M-0.32M0.87M-0.45M0.07M-0.18M0.87M-0.34M-0.27M-0.44M-0.02M-0.67M0.53M-0.14M0.94M-0.70M0.13M
Other Working Capital Changes (Quarter)
-0.06M3.53M-1.11M-0.55M1.06M-0.74M-0.52M0.51M0.27M0.09M-0.06M0.31M-0.24M-0.04M-0.69M-0.17M0.01M0.01M-0.40M0.35M
Investing Activities
Capital Expenditures (Quarter)
0.53M0.27M0.99M0.48M0.65M0.96M0.23M0.69M0.46M0.87M0.41M0.65M0.51M0.71M0.25M0.22M0.40M0.42M0.24M0.51M
Change in Acquisitions & Divestments (Quarter)
16.00M45.10M38.58M67.00M36.50M21.10M14.25M18.00M19.00M20.35M23.00M30.50M36.91M65.00M26.63M19.25M28.36M34.75M25.80M
Cash from Investing Activities (Quarter)
-84.57M-83.98M6.06M15.18M35.08M-11.94M-64.06M-13.49M-2.25M13.07M-41.06M22.35M14.29M-7.50M37.11M19.51M14.47M0.45M0.79M14.23M
Financing Activities
Other financing activities (Quarter)
0.05M0.06M0.06M0.16M-0.00M0.12M0.06M0.00M0.01M0.09M0.01M0.24M0.03M0.01M0.23M0.02M0.07M-0.03M1.10M
Cash from Financing Activities (Quarter)
329.44M0.01M0.06M0.16M0.18M0.09M0.14M0.00M0.10M0.02M0.25M0.24M0.32M0.14M0.44M0.02M0.10M0.10M1.10M
Additional items
Change in Cash (Quarter)
236.58M-98.15M-4.39M3.00M21.73M-21.42M-74.30M-26.02M-15.71M1.35M-54.71M6.33M-0.84M-20.48M23.24M5.59M1.22M-10.58M-11.49M2.24M
Free Cash Flow (Quarter)
-8.82M-14.45M-11.51M-12.82M-14.18M-10.53M-10.61M-13.22M-14.01M-12.61M-14.31M-16.91M-15.97M-13.82M-14.56M-14.16M-13.75M-11.45M-12.62M-13.61M
Net Cash Flow (Quarter)
236.58M-98.15M-4.39M3.00M21.73M-21.42M-74.30M-26.02M-15.71M1.35M-54.71M6.33M-0.84M-20.48M23.24M5.59M1.22M-10.58M-11.49M2.24M